Prelude Therapeutics
Xiaowei Wu is a Director of chemistry with experience at Prelude Therapeutics. Prior to this, Xiaowei held positions as Principal Scientist, Senior Research Scientist, and Research Scientist at the same company. Xiaowei also worked as a Research Assistant at Boston University and Peking University. Xiaowei holds a PhD in total synthesis of natural products from Boston University, an MS in Medicinal Chemistry from Peking University, and a BS in Pharmaceutical Sciences from Peking University.
Prelude Therapeutics
3 followers
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways.